Cargando…
The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
Alopecia areata (AA), a prevalent inflammatory cause of hair loss, lacks FDA-approved therapeutics for extensive cases, which are associated with very poor rates of spontaneous hair regrowth and major psychological distress. Current treatments for severe cases include broad immune-suppressants, whic...
Autores principales: | Renert-Yuval, Yael, Guttman-Yassky, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504208/ https://www.ncbi.nlm.nih.gov/pubmed/28646393 http://dx.doi.org/10.1007/s12325-017-0542-7 |
Ejemplares similares
-
Baricitinib for the Treatment of Alopecia Areata
por: Freitas, Egídio, et al.
Publicado: (2023) -
The Changing Landscape of Alopecia Areata: The Translational Landscape
por: Wang, Etienne C. E., et al.
Publicado: (2017) -
The Changing Landscape of Alopecia Areata: An Introduction
por: Han, George
Publicado: (2017) -
Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
por: Elkady, Amal, et al.
Publicado: (2017) -
An Extraordinary Colocalization of Alopecia Areata and Vitiligo
por: Ramot, Yuval, et al.
Publicado: (2010)